Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics

Journal of Infectious Diseases

Volumn 173, Issue 3, 1996, Pages 684-690

  Angiolella, Letizia ^b   Facchin, Monica ^b   Stringaro, Annarita ^b   Maras, Bruno ^b   Simonetti, Nicola ^b   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CILOFUNGIN; ENOLASE; FUNGAL PROTEIN; GLUCAN; LIPOPEPTIDE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL WALL; FUNGUS GROWTH; IMMUNOELECTRON MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METABOLISM;

EID: 0030043268     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.3.684     Document Type: Article

References (5)

1. Cassons A. Cell wall of pathogenic yeasts and implications for antimycotic therapy. Drugs Exp Clin Res 1986;12:635-43.
2. Gozalbo D, Elorza MV, Sanjuan R, Marcilla A, Valentin E, Sentandreu R. Critical steps in fungal cell wall synthesis: strategies for their inhibition. Pharmacol Ther 1993;60:337-45.
3. Hector RF. Compounds active against cell walls of medically important fungi. Clin Microbiol Rev 1993;6:1-21.
4. Angiolella L, Bromuro C, Simonetti N, Cassone A. Glucan synthesis and its inhibition by cilofungin in susceptible and resistant strain of Candida albicans. J Med Vet Mycol 1992;30:369-76.
5. Cassone A, Mason RE, Kenidge D. Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study. Sabouraudia 1981;19:97-110.